Brochures
Navigate the complexity of mAb manufacturing with Solvias’ comprehensive array of innovative testing solutions
The success of mAb therapies relies on their targeting precision, an element tied to structural and chemical integrity. However, the journey from lab to patient is fraught with stability challenges, spotlighting the critical role of advanced characterization and quality control. Solvias provides a comprehensive suite of cGMP-compliant biologics CMC testing services. Our unique blend of biological and physical-chemical testing paired with specialized services enables us to apply our deep expertise to the fastest-growing areas of biologics development.
Cutting-Edge Technology
Solvias is at the forefront of mAb analytical services, keeping pace with the constantly evolving landscape of regulatory demands. Our commitment to excellence is demonstrated through our ongoing investment in cutting-edge analytical technology. This enables us to provide mAb data that is highly sensitive, accurate, and within the strict framework of cGMP compliance. Leveraging advanced techniques and our profound expertise, we offer best-in class analytics, enabling our customers to ensure the safety and effectiveness of their drugs.
Release Testing
Analytical testing for drug substance and drug product with a robust quality system ensuring late-stage and commercial release compliance. Our efficient processes enable a rapid turnaround time of as little as 10 weeks, helping eliminate supply chain bottlenecks.
Unparalleled Expertise
Our CMC testing offerings are rooted in a deep understanding of the critical quality attributes that impact biologics development, ensuring reliable, cost-effective solutions. You enjoy direct access to our subject matter experts and project managers. By keeping technology and testing capabilities in-house, we’re able to provide accurate results rapidly, helping avoid costly program delays.
Contact us for a complimentary consultation
